Omega-3 PUFA of marine origin reduce adiposity in animals fed a high-fat diet. Our aim was to learn whether EPA and DHA could limit development of obesity and reduce cellularity of adipose tissue and whether other dietary FA could influence the effect of EPA/DHA. Weight gain induced by composite high-fat diet in C57BL/6J mice was limited when the content of EPA/DHA was increased from 1 to 12% (wt/wt) of dietary lipids. Accumulation of adipose tissue was reduced, especially of the epididymal fat. Low ratio of EPA to DHA promoted the effect. A higher dose of EPA/DHA was required to reduce adiposity when admixed to diets that did not promote obesity, the semisynthetic high-fat diets rich in EFA, either alpha-linolenic acid (ALA, 18:3 n-3, the precursor of EPA and DHA) or linoleic (18:2 n-6) acid. Quantification of adipose tissue DNA revealed that except for the diet rich in ALA the reduction of epididymal fat was associated with 34-50% depression of tissue cellularity, similar to the 30% caloric restriction in the case of the high-fat composite diet. Changes in plasma markers and adipose gene expression indicated improvement of lipid and glucose metabolism due to EPA/DHA even in the context of the diet rich in ALA. Our results document augmentation of the antiadipogenic effect of EPA/DHA during development of obesity and suggest that EPA/DHA could reduce accumulation of body fat by limiting both hypertrophy and hyperplasia of fat cells. Increased dietary intake of EPA/DHA may be beneficial regardless of the ALA intake.

Department of Adipose Tissue Biology and Centre for Integrated Genomics Institute of Physiology Academy of Sciences of the Czech Republic 142 20 Prague Czech Republic

Erratum v

Lipids. 2005 Jan;40(1):115 PubMed

Zobrazit více v PubMed

Exp Biol Med (Maywood). 2003 Nov;228(10 ):1118-23 PubMed

Lipids. 2002 Dec;37(12):1113-23 PubMed

Ann Nutr Metab. 1999;43(2):86-97 PubMed

J Nat Prod. 2001 Jun;64(6):745-9 PubMed

Metabolism. 1990 Mar;39(3):217-9 PubMed

Int J Obes Relat Metab Disord. 1997 Nov;21(11):955-62 PubMed

J Nutr. 2001 Oct;131(10 ):2636-42 PubMed

J Lipid Res. 2003 Feb;44(2):271-9 PubMed

Am J Physiol. 1992 Jun;262(6 Pt 2):R1025-32 PubMed

Am J Physiol. 1994 Dec;267(6 Pt 1):E975-82 PubMed

Int J Obes. 1985;9(6):443-9 PubMed

Proc Nutr Soc. 1999 Aug;58(3):633-46 PubMed

Biochem Biophys Res Commun. 1999 May 27;259(1):85-90 PubMed

Eur J Cell Biol. 1981 Dec;26(1):11-20 PubMed

Metabolism. 1996 Dec;45(12):1539-46 PubMed

Biochem Biophys Res Commun. 1999 Apr 21;257(3):879-85 PubMed

J Hum Nutr Diet. 2004 Oct;17 (5):449-59 PubMed

Int J Obes Relat Metab Disord. 1997 Aug;21(8):637-43 PubMed

Int J Obes Relat Metab Disord. 1993 Apr;17(4):223-36 PubMed

Biol Neonate. 2003;83(2):136-45 PubMed

Diabetes. 1988 Sep;37(9):1163-7 PubMed

Am J Physiol. 1998 Mar;274(3 Pt 1):E527-33 PubMed

J Clin Invest. 1995 Dec;96(6):2914-23 PubMed

J Anim Sci. 2004 Mar;82(3):916-24 PubMed

Am J Clin Nutr. 1999 Nov;70(5):817-25 PubMed

J Lipid Res. 1997 Oct;38(10):1963-72 PubMed

J Lipid Res. 1994 Apr;35(4):592-600 PubMed

Obes Res. 2004 Jan;12(1):131-40 PubMed

Am J Physiol. 1996 May;270(5 Pt 1):E768-75 PubMed

Am J Physiol. 1996 May;270(5 Pt 1):E776-86 PubMed

Metabolism. 1998 Sep;47(9):1089-96 PubMed

Biochem J. 2002 Jun 1;364(Pt 2):369-76 PubMed

Am J Physiol. 1993 Jun;264(6 Pt 2):R1111-8 PubMed

J Nutr. 1998 Jun;128(6):923-6 PubMed

Curr Opin Clin Nutr Metab Care. 2004 Mar;7(2):151-6 PubMed

Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD

Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue

The Anti-Obesogenic Effect of Lean Fish Species is Influenced by the Fatty Acid Composition in Fish Fillets

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport

Reduced Number of Adipose Lineage and Endothelial Cells in Epididymal fat in Response to Omega-3 PUFA in Mice Fed High-Fat Diet

Plasma Acylcarnitines and Amino Acid Levels As an Early Complex Biomarker of Propensity to High-Fat Diet-Induced Obesity in Mice

Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice

Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice

Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids

Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet

The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice

AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids

n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet

Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet

Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat